Expires March 1, 2019
Length: 20 minutes, 44 seconds
This presentation provides an overview of heparin-induced thrombocytopenia (HIT) laboratory testing and touches on the important aspects of ELISA and functional assays. Dr. Deepti Warad discusses the evolving role of screening assays in HIT testing that are widely available, and she highlights the challenges of interpretation of laboratory results and variability of gold-standard assays.
Upon completion of this activity, participants should be able to:
- Outline laboratory testing for heparin-induced thrombocytopenia.
- Discuss the evolving role of screening assays in HIT diagnosis.
- Review the challenges with interpreting laboratory results and the variability of gold-standard assays.
This program is appropriate for clinicians, pathologists, medical technologists, nurses, pharmacists, and other allied health staff.
Level of Instruction
Deepti Warad, M.B.B.S.
Assistant Professor of Pediatrics
Mayo Clinic College of Medicine and Science
Senior Associate Consultant
Department of Pediatric Hematology and Oncology
Note: This program does not qualify for ASCLS P.A.C.E.® because it does not meet the minimum requirement of 30 minutes in length.
Note: This program does not qualify for State of Florida or State of California credit because it does not meet the minimum requirement of 50 minutes in length.